Your session is about to expire
← Back to Search
Exercise Program for Pediatric Cancer Mobility
Study Summary
This trial is testing an exercise program to see if it can help kids with cancer who are undergoing blood stem cell transplants. The program uses stickers as rewards to help kids stay active.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I, or my guardian, agree to sign up for the Fitbit study PA18-0130.I am admitted to a hospital for a stem cell transplant to treat cancer.I cannot do any physical activity due to severe health issues like breathing problems or active bleeding.I am between 6 and 30 years old.
- Group 1: Supportive Care (TEAM Me)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available in this trial for participants?
"Affirmative. The information from clinicaltrials.gov demonstrates that this trial is actively looking for participants, with the initial posting on November 13th 2020 and most recent update on April 21st 2022. This research project requires enrollment of 60 individuals across two separate sites."
For what types of individuals is this research initiative most suitable?
"To qualify for this clinical research, applicants must be aged between 6 and 29 with evidence of lymphoid cells. Currently, a total of 60 individuals are being admitted to the trial."
Does this experiment have an age restriction, and if so, what is it?
"Eligibility for enrolment in this clinical trial requires a person to be between 6 and 29 years of age."
How many participants are involved in this experimental protocol?
"Affirmative. According to clinicaltrials.gov, the trial is currently recruiting participants; it was first posted on November 13th 2020 and recently updated on April 21st 2022. There are 60 spots available between two sites."
What goals has this clinical trial set forth?
"The primary purpose of this research is to monitor the prevalence of adverse events in patients up to 21 days after a hematopoietic stem cell transplant (HSCT). Secondary objectives include assessing changes in Wee Functional Independence Measure (FIM)/FIM, gross grip hand strength, and timed up and go tests. Statistical analysis such as descriptive statistics, Wilcoxon rank sum test, Wilcoxon signed-rank test, repeated measures analysis will be performed with controlling for potential confounding factors like age, gender etc., all 2-sided testing at 0.05 significance level."
Share this study with friends
Copy Link
Messenger